retatrutide fda status 2025 Retatrutide: Is FDA-Approved for Weight Loss Yet? retatrutide approval status october 2025

Regulatory Status: Please note that as of early 2026, Retatrutide remains an investigational compound

Do not assume that rectal bleeding is simply a side effect of Ozempic

For example, you will need to have a body mass index (BMI) of: 30 kg/m2 or more, or at least 28 kg/m2 and a weight-related health condition such as type 2 diabetes, high blood pressure, or high blood cholesterol levels To get orlistat on the NHS, you will need to make an appointment with your GP, so they can assess if the medication is safe and suitable for you to take

10.1080/088800199277489 3 ArcanP.BozkurtO.CavusogluD.GencpnarP.HaspolatS.DumanO.et al (2020)

Evidence supporting the kidney and cardiovascular benefits of the GLP-1 receptor agonists comes from large clinical trials enrolling patients with type 2 diabetes, cardiovascular disease, chronic kidney disease (CKD), or a combination of these conditions (Figure 1)